Literature DB >> 8382471

Parathyroid hormone and T-cellular immunity in uremic patients in replacement dialytic therapy.

D Angelini1, A Carlini, R Giusti, R Grassi, E Mei, I Fiorini, L Mazzotta, A Antonelli.   

Abstract

We studied 54 patients in replacement dialytic therapy divided into two groups: Group 1, 26 patients with normal parathyroid hormone (PTH) (10-80 pg/ml): and Group 2, 28 patients with elevated PTH (80-400 pg/ml). Total T lymphocytes, CD4, CD8, and CD4/CD8 ratio were evaluated. We found a reduction of total T lymphocytes in both groups compared with controls. A decrease of CD4 and CD4/CD8 ratio with a rise of CD8 occurred in Group 2 but not in Group 1. In Group 2, PTH presented a linear correlation with CD8 and a reverse correlation with total T cells. CD4, and CD4/CD8 ratio. PTH might act on T-cellular immunity with an immunosuppressive effect from the earlier phases of hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382471     DOI: 10.1111/j.1525-1594.1993.tb00415.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  3 in total

1.  Beyond Bone: Infectious Diseases and Immunity in Parathyroid Disorders.

Authors:  Valeria Hasenmajer; Giulia Puliani; Marianna Minnetti; Emilia Sbardella; Claudio M Mastroianni; Gabriella D'Ettorre; Andrea M Isidori; Daniele Gianfrilli
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Effects of parathyroid hormone on immune function.

Authors:  Abdallah Sassine Geara; Mario R Castellanos; Claude Bassil; Georgia Schuller-Levis; Eunkue Park; Marianne Smith; Michael Goldman; Suzanne Elsayegh
Journal:  Clin Dev Immunol       Date:  2010-09-16

3.  Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats.

Authors:  Mony Shuvy; Suzan Abedat; Ronen Beeri; Haim D Danenberg; David Planer; Iddo Z Ben-Dov; Karen Meir; Jacob Sosna; Chaim Lotan
Journal:  Cardiovasc Res       Date:  2008-04-05       Impact factor: 10.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.